Abon Biopharma Patents – Insights & Stats (Updated 2024)

Abon Biopharma has a total of 348 patents globally, out of which 257 have been granted. Of these 348 patents, more than 39% patents are active. China is where Abon Biopharma has filed the maximum number of patents, followed by United States of America and Hong Kong (S.A.R.). Parallelly, China seems to be the main focused R&D centre and also is the origin country of Abon Biopharma.

Abon Biopharma was founded in the year 2003. The Company manufactures in vitro diagnostic products. The Company produces and sells ketamine drug screen test devices, fecal occult blood test devices, syphilis ultra-rapid test devices, chlamydia antigen test devices, and other products.

Do read about some of the most popular patents of Abon Biopharma which have been covered by us in this article and also you can find Abon Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Abon Biopharma patent portfolio.

How many patents does Abon Biopharma have?

Abon Biopharma has a total of 348 patents globally. These patents belong to 238 unique patent families. Out of 348 patents, 139 patents are active.

How Many Patents did Abon Biopharma File Every Year?

Abon Biopharma Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAbon Biopharma Applications FiledAbon Biopharma Patents Granted
20211
20205
201917
2018823
20171531
20162125
20152823
20144526
20134816
20123527
20113916

How many Abon Biopharma patents are Alive/Dead?

Abon Biopharma Patent Portfolio

How Many Patents did Abon Biopharma File in Different Countries?

Abon Biopharma Worldwide Patent Filing

Countries in which Abon Biopharma Filed Patents

CountryPatents
China289
United States of America13
Hong Kong (S.A.R.)10
Europe8
Germany3
Spain2
Austria2
Taiwan2
United Kingdom1
Canada1

Where are Research Centres of Abon Biopharma Patents Located?

R&D Centers of Abon Biopharma

10 Best Abon Biopharma Patents

USD762860S1 is the most popular patent in the Abon Biopharma portfolio. It has received 30 citations so far from companies like Life Technologies Corporation, Neogen Corporation and Altopa, Inc.

Below is the list of 10 most cited patents of Abon Biopharma:

Publication NumberCitation Count
USD762860S130
CN101876661A30
CN101545864A21
CN105829861A19
CN101059404A19
WO2008014709A119
CN201212889Y16
CN203869898U14
CN201464268U14
CN203083995U13

What Percentage of Abon Biopharma US Patent Applications were Granted?

Abon Biopharma (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 50.0%.

Below are the key stats of Abon Biopharma patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Abon Biopharma?

Law FirmTotal ApplicationsSuccess Rate
Dla Piper Llp Us450.00%

What are Abon Biopharma key innovation segments?

What Technologies are Covered by Abon Biopharma?

The chart below distributes patents filed by Abon Biopharma in different countries on the basis of the technology protected in patents. It also represents the markets where Abon Biopharma thinks it’s important to protect particular technology inventions.

R&D Focus: How has Abon Biopharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Abon Biopharma?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.